SARS-CoV-2 Selectively Induces the Expression of Unproductive Splicing Isoforms of Interferon, Class I MHC, and Splicing Machinery Genes

• Published in: International journal of molecular sciences Vol. 25; no. 11; p. 5671
• Main Authors: Dias, Thomaz Lüscher, Mamede, Izabela, de Toledo, Nayara Evelin, Queiroz, Lúcio Rezende, Castro, Ícaro, Polidoro, Rafael, Del-Bem, Luiz Eduardo, Nakaya, Helder, Franco, Glória Regina
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.06.2024; MDPI
• Subjects: alternative splicing; Antigens; Biological response modifiers; Chemokines; Coronaviruses; COVID-19; Cytokines; Genes; Genetic engineering; Genetic research; Health aspects; immune response; Infections; Interferon; isoforms; Kinases; Pathogens; Protein expression; Proteins; RNA processing; SARS-CoV-2; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; transcriptomics; Tumor necrosis factor-TNF; Viral infections; Viruses; Brazil
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25115671

RNA processing is a highly conserved mechanism that serves as a pivotal regulator of gene expression. Alternative processing generates transcripts that can still be translated but lead to potentially nonfunctional proteins. A plethora of respiratory viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), strategically manipulate the host’s RNA processing machinery to circumvent antiviral responses. We integrated publicly available omics datasets to systematically analyze isoform-level expression and delineate the nascent peptide landscape of SARS-CoV-2-infected human cells. Our findings explore a suggested but uncharacterized mechanism, whereby SARS-CoV-2 infection induces the predominant expression of unproductive splicing isoforms in key IFN signaling, interferon-stimulated (ISGs), class I MHC, and splicing machinery genes, including IRF7, HLA-B, and HNRNPH1. In stark contrast, cytokine and chemokine genes, such as IL6 and TNF, predominantly express productive (protein-coding) splicing isoforms in response to SARS-CoV-2 infection. We postulate that SARS-CoV-2 employs an unreported tactic of exploiting the host splicing machinery to bolster viral replication and subvert the immune response by selectively upregulating unproductive splicing isoforms from antigen presentation and antiviral response genes. Our study sheds new light on the molecular interplay between SARS-CoV-2 and the host immune system, offering a foundation for the development of novel therapeutic strategies to combat COVID-19.